Reach and Cost-Effectiveness of the PrePex Device for Safe Male Circumcision in Uganda

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Duffy, Kevin ^a   Galukande, Moses ^b   Wooding, Nick ^c   Dea, Monica ^d   Coutinho, Alex ^e  

^a International Medical Group   (Uganda)

^b MULAGO HOSPITAL   (Uganda)

^c International Health Science University   (Uganda)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; CIRCUMCISION; CIRCUMCISION DEVICE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; QUALITY CONTROL; UGANDA;

CIRCUMCISION, MALE; COST SAVINGS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; EQUIPMENT AND SUPPLIES; HEALTH POLICY; HIV INFECTIONS; HUMANS; MALE; UGANDA; UNITED STATES; UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT;

EID: 84878076292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063134     Document Type: Article

References (20)

1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Medicine 2(11): e298.
2. Bailey RC, Moses S, Parker CB, Agot K, Maclean I,et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369(9562): 643-56.
3. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369(9562): 657-66.
4. WHO and UNAIDS (2007) New Data on Male Circumcision and HIV Prevention: Research Implications for Policy and Programming. Montreux, Switzerland.
5. Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, et al. (2011) Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Medicine 8(11): p.e1001132.
6. Uganda AIDS Commission (2011) The National Priority Action Plan.
7. Reed JB, Njeuhmeli E, Thomas AG, Bacon MC, Bailey R, et al. (2012) Voluntary Medical Male Circumcision: An HIV Prevention Priority for PEPFAR. JAIDS 60(August): 88-95.
8. Bitega JP, Ngeruka ML, Hategekimana T, Asiimwe A, Binagwaho A, (2011) Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes 58(5): e127-34.
9. Binagwaho A, et al. (2011) A prospective, randomized, open-label trial comparing the PrePex™ device to surgical circumcision for rapid scale-up of male circumcision in resource-limited settings (Protocol Number RMC-01). Kigali, Rwanda, 2011.
10. Mutabazi V, et al. (2011) One arm, open label, prospective, cohort field study to assess the safety and efficacy of the PrePex™ device for scale-up of non-surgical circumcision when performed by nurses in resource-limited settings for HIV prevention (Protocol RMC-03). Kigali, Rwanda, 2012.
11. Galukande M, Bbale D, Duffy K, Wooding N, Rackara S, et al. (2012) Mass Safe Male Circumcision: early lessons from a Ugandan urban site - A case study. PAMJ 13: 88.
12. Shepard DS, Hodgkin D, Anthony Y (1998) Analysis of Hospital Costs: A Manual For Managers. Institute for Health Policy, Heller Graduate School Brandeis University, Waltham, MA, USA. WHO, Geneva 2000.
13. Bollinger L, DeCormier Plosky W, Stover J (2009) Male Circumcision: Decision Makers' Program Planning Tool, Calculating the Costs and Impacts of a Male Circumcision Program. Washington, DC: Futures Group, Health Policy Initiative, Task Order 1.
14. Kahn JG, Marseille E, Auvert B, (2006) Cost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting. PLoS Medicine 3(12): 10.
15. WHO (2012) Use of devices for adult male circumcision in public health HIV prevention programmes.
16. WHO (2012a) World Health Statistics 2012. Available: http://www.who.int/gho/publications/world_health_statistics/2012/en/. Accessed 2012 September 26.
17. Kuznik A, Lamorde M, Sekavuga D, Picho B, Coutinho A, (2012) Medical male circumcision for HIV/AIDS prevention in Uganda - the cost of disposable versus re-usable circumcision kits. Tropical Doctor 42(1): 5-7.
18. Galukande M, Duffy K, Bitega JP, Rackara S, Bbaale Sekavuga D, et al. (2013) Adverse events profile of PrePex a non surgical device for adult Male Circumcision in a Ugandan urban setting. In Press 2013.
19. Odaga J, Okiria C (2010) Providing CD4 Cell Count Tests to Hard-to- reach Communities in Northern Uganda Programme Reach and Cost-effectiveness of an Outreach Delivery Model.
20. WHO (2010) Considerations for implementing models for optimizing the volume and efficiency of male circumcision services. [Kim Eva Dickson (WHO), Jason Reed (CDC, USA) and Dino Rech (PSI/WHO Consultant)].